caretrace.iopowered by▸healthparse
SearchCohort Builder
Tools▾
KOL FinderTerritoriesDrug Compare
AI Query
Browse▾
By stateBy specialty
Pricing
SearchCohort BuilderToolsKOL FinderTerritoriesDrug CompareAI QueryBrowseBy stateBy specialtyPricing
PROVIDER PROFILE · NPI 1194708586

Dean WingerchukM.D.

PRACTICEMAYO CLINIC ARIZONASee all providers at this practice →
NeurologyScottsdale, AZI
CROSS-REFERENCE

Related data on other Healthparse brands

ProviderScore
OIG/SAM exclusion screening, sanctions history
© 2026 CareTrace
PricingContactPrivacyTerms
FACILITY AFFILIATIONS

Hospital & Facility Affiliations (1)

CCN 030103
Hospital
REFERRAL NETWORK

Where Dean Wingerchuk's patients come from & go

Directional shared-patient flow from Medicare claims — who sends patients to this provider (inbound) and where this provider's patients go next (outbound). 2 inbound referrers · 6 outbound destinations.

Receives referrals from
Inbound — who sends patients here
PhysicianPatientsVisits
MAYO CLINIC ARIZONA77193
Geoffrey Fletcher
Diagnostic Radiology · Scottsdale, AZ
1116
Refers patients to
Outbound — where patients go next
PhysicianPatientsVisits
Mayo Clinic Arizona
Clinical Laboratory · Scottsdale, AZ
43138
MAYO CLINIC ARIZONA41106
HERNANDEZ, JAMES1625
Kent Nelson
Diagnostic Radiology · Scottsdale, AZ
1431
Geoffrey Fletcher
Diagnostic Radiology · Scottsdale, AZ
1222
Ameet Patel
Diagnostic Radiology · Scottsdale, AZ
1124
Source: CMS Physician Shared Patient Patterns (30-day window, Medicare FFS). Direction = a beneficiary seen by the first provider, then the second, within 30 days; a proxy for referral, not a documented referral. Pairs with fewer than 11 shared beneficiaries are suppressed.
MEDICARE UTILIZATION · PART B · 2024
Total beneficiaries
168
Unique beneficiaries
—
Total services
173
Distinct HCPCS
4
Medicare payment
$20K
Peer benchmark
Q1
Q2
Q3
Q4
Q5
Total Medicare services vs. 340 Neurology providers in AZ — bottom quintile (cohort median 784).
PRESCRIBING · PART D · 2024
Total Rx claims
120
Beneficiaries
—
Total drug cost
$366K
Distinct drugs
6
Brand share
45.0%
Top prescribed drugs
Gabapentin35 claims
Dalfampridine21 claims
Satralizumab-Mwge19 claims
Baclofen18 claims
Fingolimod Hcl14 claims
QUALITY · MIPS · 2024
Final MIPS score
86.5
Quality
78.3
Cost
76.6
Improvement activities
40.0
Promoting interop.
100.0
Payment adjustment
0.48%
Group
INDUSTRY PAYMENTS · OPEN PAYMENTS · 2024
Total received
$45K
Payment records
35
By payment type
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program$23K
Consulting Fee$12K
Travel and Lodging$8K
Food and Beverage$1K